Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ0800007	盐酸马普替林	maprotiline hydrochloride	Active ingredient	Chemical Drugs	License Renew	2008-01-15	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2008-08-06	view
JYHB1901452	LCZ696片	sacubitril;valsartan	Tablet	Chemical Drugs(2.4)	Supplementary Application	2019-12-09	Novartis Pharma AG	Novartis Pharma Schweiz AG;Novartis Singapore Pharmaceutical Manufacturing Private Ltd	In Review	2019-12-07	view
JYHB1901451	LCZ696片	sacubitril;valsartan	Tablet	Chemical Drugs(2.4)	Supplementary Application	2019-12-09	Novartis Pharma AG	Novartis Pharma Schweiz AG;Novartis Singapore Pharmaceutical Manufacturing Private Ltd	In Review	2019-12-07	view
JYHB1901450	LCZ696片	sacubitril;valsartan	Tablet	Chemical Drugs(2.4)	Supplementary Application	2019-12-09	Novartis Pharma AG	Novartis Pharma Schweiz AG;Novartis Singapore Pharmaceutical Manufacturing Private Ltd	In Review	2019-12-07	view
JYHB1701127	LJN452胶囊	tropifexor	Capsule	Chemical Drugs(1)	Supplementary Application	2017-09-08	Novartis Pharma AG	Novartis Pharma Schweiz AG;Aptuit (Verona) Srl	Certificate Issued	2018-02-22	view
JYHB1701126	LJN452胶囊	tropifexor	Capsule	Chemical Drugs(1)	Supplementary Application	2017-09-06	Novartis Pharma AG	Novartis Pharma Schweiz AG;Aptuit (Verona) Srl	Certificate Issued	2018-02-22	view
JYHB1101024	注射用帕瑞肽	pasireotide diaspartate	Lyophilized	Chemical Drugs	Supplementary Application	2011-12-08	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2012-07-12	view
JYHB1101023	注射用帕瑞肽	pasireotide diaspartate	Lyophilized	Chemical Drugs	Supplementary Application	2011-12-08	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2012-07-12	view
JYHB1000042	注射用帕瑞肽	pasireotide diaspartate	Lyophilized	Chemical Drugs	Supplementary Application	2010-02-23	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2010-07-20	view
JYHB1000041	注射用帕瑞肽	pasireotide diaspartate	Lyophilized	Chemical Drugs	Supplementary Application	2010-02-23	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2010-07-20	view
JYHB0800836	注射用帕瑞肽	pasireotide diaspartate	Lyophilized	Chemical Drugs	Supplementary Application	2009-01-04	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-06-16	view
JYHB0800835	注射用帕瑞肽	pasireotide diaspartate	Lyophilized	Chemical Drugs	Supplementary Application	2009-01-04	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-06-16	view
JYHB0800834	注射用帕瑞肽	pasireotide diaspartate	Lyophilized	Chemical Drugs	Supplementary Application	2009-01-04	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-06-16	view
JXSL1800043	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-26	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-25	view
JXSL1800042	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-29	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-27	view
JXSL1800041	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-26	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-25	view
JXSL1800040	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-10-29	Novartis Pharma AG	Novartis Pharma Schweiz AG	In Review	2018-10-27	view
JXSL1800007	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-02-22	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-08-27	view
JXSL1800006	ACZ885	canakinumab	Injection	Biological Products	Import Drug Application	2018-02-22	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-08-27	view
JXSL1700041	PDR001	spartalizumab	Other	Biological Products	Import Drug Application	2017-08-16	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2017-12-20	view